MTOR and cancer: Enhanced activity of the phosphoinositide 3-kinase (PI3K)/AKT/mechanistic target of rapamycin (mTOR) signaling pathway is among the most frequently observed changes in cancer and is associated with tumor invasiveness, survival, and proliferation1.